Close Menu

Columbia

Columbia University of New York has received US Patent No.

This is the second in a series of profiles of projects awarded NHGRI grants to develop policy guidelines on how and when to disclose secondary information to the subjects of genomic research studies.

A team from Columbia University is carrying out a set of interviews and surveys they intend to use to create guidelines for acquiring informed consent from subjects of genomic sequencing studies for the return of "incidental," or secondary, findings.

Columbia University of New York has received US Patent No.

Fluidigm of South San Francisco, Calif., has received US Patent No.

This story was originally posted on March 29.
By Justin Petrone

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Columbia University's trustees today sued Illumina claiming infringement of five patents covering methods for next-generation sequencing.

Columbia University of New York has received US Patent No. 8,133,492, "Pneumococcus polysaccharide-related vaccines." Nitrocellulose-based or hydrogel-based microarrays and methods of making them are claimed.

By Justin Petrone
Chromosomal microarrays could eventually become the standard of care for prenatal genetic testing in the US if implemented correctly, according to the results of a recent study.

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.